JHS Svendgaard Laboratories Ltd
JHSJHS Svendgaard Laboratories Ltd
JHSPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-17.62 | 1.21 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.18 | 10.16 | 1.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
JHS Svendgaard Laboratories Limited offers oral care products (toothbrushes, toothpastes, mouthwash, whitening gels and denture products) for national and global FMCG brands.
Peers
Compare with peersGodrej Consumer Products Ltd
Dabur India Ltd
Marico Ltd
Colgate-Palmolive (India) Ltd
Procter & Gamble Hygiene and Health Care Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 96.53 | 105.49 | 172.54 | 130.65 | 152.95 | 108.31 | 95.64 | 96.13 | 75.11 | 85.02 | ||||||||||
Raw Materials | 69.84 | 35.82 | 49.85 | 61.28 | 73.03 | 44.05 | 36.34 | 33.98 | 24.83 | 78.23 | ||||||||||
Power & Fuel Cost | 3.00 | 3.45 | 3.42 | 3.26 | 3.30 | 2.98 | 2.91 | 2.90 | 2.73 | |||||||||||
Employee Cost | 7.23 | 8.66 | 12.10 | 13.52 | 13.44 | 10.08 | 11.45 | 10.19 | 9.21 | |||||||||||
Selling & Administrative Expenses | 5.53 | 7.22 | 9.55 | 10.26 | 12.02 | 4.53 | 4.68 | 9.12 | 4.38 | |||||||||||
Operating & Other expenses | 21.71 | 38.22 | 51.65 | 36.26 | 46.29 | 37.21 | 31.71 | 56.33 | 30.59 | |||||||||||
EBITDA | -10.78 | 12.12 | 45.97 | 6.07 | 4.87 | 9.46 | 8.55 | -16.39 | 3.37 | 6.79 | ||||||||||
Depreciation/Amortization | 10.49 | 6.36 | 6.81 | 7.09 | 8.76 | 7.25 | 7.05 | 6.02 | 6.35 | 7.48 | ||||||||||
PBIT | -21.27 | 5.76 | 39.16 | -1.02 | -3.89 | 2.21 | 1.50 | -22.41 | -2.98 | -0.69 | ||||||||||
Interest & Other Items | 0.36 | 0.62 | 0.74 | 1.03 | 1.95 | 1.24 | 1.39 | 0.55 | 0.46 | 0.47 | ||||||||||
PBT | -21.63 | 5.14 | 38.42 | -2.05 | -5.84 | 0.97 | 0.11 | -22.96 | -3.44 | -1.16 | ||||||||||
Taxes & Other Items | 0.00 | -16.80 | 12.28 | -1.37 | -3.87 | -0.24 | 4.16 | -27.00 | -18.89 | 10.54 | ||||||||||
Net Income | -21.63 | 21.94 | 26.14 | -0.68 | -1.97 | 1.21 | -4.05 | 4.04 | 15.45 | -11.70 | ||||||||||
EPS | -6.92 | 5.30 | 4.91 | -0.11 | -0.32 | 0.19 | -0.62 | 0.56 | 1.96 | -1.49 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Consumer StaplesFMCG - Personal Products
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
JHS Svendgaard Laboratories Ltd | 13.34 | 1.21 | — |
Godrej Consumer Products Ltd | -206.93 | 9.21 | 1.32% |
Dabur India Ltd | 48.76 | 8.72 | 1.08% |
Marico Ltd | 53.63 | 19.05 | 1.54% |
Price Comparison
Compare JHS with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 3.17%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.18%
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.54%
Shareholding Pattern
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
JHS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Net Loss of JHS Svendgaard Laboratories reported to Rs 10.32 crore in the quarter ended September 2024 as against net loss of Rs 0.73 crore during the previous quarter ended September 2023. Sales rose 3.96% to Rs 19.68 crore in the quarter ended September 2024 as against Rs 18.93 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales19.6818.93 4 OPM %-4.322.11 - PBDT-0.090.51 PL PBT-2.07-0.99 -109 NP-10.32-0.73 -1314 Powered by Capital Market - Live
JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
JHS Svendgaard Laboratories announced that the 20th Annual General Meeting (AGM) of the company will be held on 10 September 2024.Powered by Capital Market - Live
Net Loss of JHS Svendgaard Laboratories reported to Rs 0.63 crore in the quarter ended June 2024 as against net loss of Rs 2.59 crore during the previous quarter ended June 2023. Sales rose 53.96% to Rs 24.48 crore in the quarter ended June 2024 as against Rs 15.90 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.4815.90 54 OPM %8.05-13.40 - PBDT2.17-1.84 LP PBT0.20-3.16 LP NP-0.63-2.59 76 Powered by Capital Market - Live
JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Sheetal Cool Products Ltd leads losers in ‘B’ group
Mallcom (India) Ltd leads gainers in ‘B’ group
JHS Svendgaard Laboratories reports consolidated net loss of Rs 1.53 crore in the December 2022 quarter
JHS Svendgaard Laboratories reports consolidated net loss of Rs 0.22 crore in the September 2022 quarter
JHS Svendgaard Consolidated September 2021 Net Sales At Rs 24.64 Crore, Down 22.2% Y-o-Y
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -10.48%, vs industry avg of 6.72%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.32% to 0.13%